BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23527733)

  • 1. Expression of CD7, CD20 and CDX-2 in a secondary signet-ring cell tumor of the prostate: a case report.
    Cimino S; Russo GI; Favilla V; Fragala E; Collura Z; Zanghi A; Castelli T; Madonia M; Morgia G
    Int J Immunopathol Pharmacol; 2013; 26(1):269-72. PubMed ID: 23527733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF; Shi HR; Sun HM; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract]   [Full Text] [Related]  

  • 4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary signet-ring cell tumour of the prostate derived from a primary gastric malignancy.
    Cobo Dols M; Muñoz Gallardo S; Peláez Angulo J; Algarra García R; Fuente Lupiáñez C; Gil Calle S; Villar Chamorro E; Montesa Pino A; Alcaide García J; Ales Díaz I; Gutiérrez Calderón V; Carabante Ocón F; Benavides Orgaz M
    Clin Transl Oncol; 2005 Oct; 7(9):409-12. PubMed ID: 16238976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic signet-ring cell carcinoma: case report and literature review.
    Kuroda N; Yamasaki I; Nakayama H; Tamura K; Yamamoto Y; Miyazaki E; Naruse K; Kiyoku H; Hiroi M; Enzan H
    Pathol Int; 1999 May; 49(5):457-61. PubMed ID: 10417691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signet ring cell carcinoma in the prostate.
    Kendall A; Corbishley CM; Pandha HS
    Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):105-7. PubMed ID: 15074731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bladder metastasis of signet-ring cell adenocarcinoma from the stomach].
    Valero Puerta JA; Medina Pérez M; García Carriazo M; Valpuesta Fernández I; Sánchez González M; Mompean FO
    Arch Esp Urol; 2000 Nov; 53(9):839-41. PubMed ID: 11196392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary signet ring cell tumour of the prostate.
    Plancke HR; Delaere KP; Theunissen P
    Urol Int; 1994; 52(4):223-4. PubMed ID: 8030172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
    Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
    Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
    Saad RS; Ismiil N; Dubé V; Nofech-Mozes S; Khalifa MA
    Am J Clin Pathol; 2009 Oct; 132(4):531-8. PubMed ID: 19762530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathologic diagnosis and histogenesis of primary signet ring cell carcinoma of the prostate].
    Jiang Z; Zhang H; Chen J; Liu L; Zhou J
    Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):514-7. PubMed ID: 12622902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Signet ring-cell carcinoma of the prostate: a case report].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Sep; 50(9):645-7. PubMed ID: 15518133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of signet ring cell adenocarcinoma of the prostate.
    Bonetti LR; Lupi M; Stauder E; Bergamini S; Scuri M; Maiorana A
    Pathologica; 2011 Apr; 103(2):40-2. PubMed ID: 21797141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of urinary bladder: A report of two patients.
    Kumari N; Vasudeva P; Kumar A; Agrawal U
    J Cancer Res Ther; 2015; 11(4):1033. PubMed ID: 26881627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.